High expression of PD-L1 in tumor cells in RA-DLBCL patients was more common in the RA group with the highest cumulative disease activity, indicating an association between tumor PD-L1 expression and the severity of the rheumatic disease. This evidence concerns the gene CD274 and neoplasm.